Argatroban and hepatic function abnormal 
Argatroban and hepatic function abnormal Patient Reports February 13, 2012
Argatroban Side Effects Report #5186453-2
Argatroban side effect was reported by a Health Professional from JAPAN on Dec 04, 2006. Female patient was diagnosed with skin ulcer and was treated with Argatroban. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, hepatic function abnormal. Argatroban dosage: 20 MG, QD, INTRAVENOUS, IV DRIP. Patient recovered.
Argatroban Side Effects Report #5226806-7
Argatroban side effect was reported by a Consumer or non-health professional from JAPAN on Dec 24, 2006. Male patient, 41 years of age, was diagnosed with pain in extremity, skin ulcer and was treated with Argatroban. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bacterial infection
, blood alkaline phosphatase increased, c-reactive protein increased, cholecystitis, gamma-glutamyltransferase increased, hepatic function abnormal, off label use. Argatroban dosage: unknown. During the same period patient was treated with WARFARIN, SOLDEM. Patient recovered.Argatroban Side Effects Report #5427464-9
Argatroban side effect was reported by a Pharmacist from UNITED STATES on Aug 24, 2007. Female patient, 73 years of age, weighting 257.9 lb, was diagnosed with heparin-induced thrombocytopenia and was treated with Argatroban. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, dialysis
, hepatic function abnormal, renal failure acute. Argatroban dosage: unknown. Patient recovered.Argatroban Side Effects Report #5671888-1
Argatroban side effect was reported by a Consumer or non-health professional from JAPAN on Feb 27, 2008. Male patient, 60 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Argatroban. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, blood alkaline phosphatase abnormal, blood bilirubin abnormal, blood lactate dehydrogenase abnormal, gamma-glutamyltransferase abnormal, hepatic function abnormal. Argatroban dosage: unknown. During the same period patient was treated with AMPHOTERICIN B, ANTIBIOTICS. Patient was hospitalized and became disabled. Patient recovered.
Argatroban Side Effects Report #5422308-3
Argatroban side effect was reported by a Health Professional from JAPAN on Aug 02, 2007. Male patient, 71 years of age, was diagnosed with cerebral thrombosis and was treated with Argatroban. After drug was administered, patient experienced the following side effects: blood fibrinogen increased, deep vein thrombosis
, hepatic function abnormal, liver disorder, pneumonia aspiration, restlessness. Argatroban dosage: 60 MG, BID, INTRAVENOUS. During the same period patient was treated with RADICUT, GRTPA, ISOSORBIDE DINITRATE, LOW MOLECULAR DEXTRAN, FAMOTIDINE, ASPIRINA BAYER, LANSOPRAZOLE. Patient recovered.Argatroban Side Effects Report #5473045-0
Argatroban side effect was reported by a Consumer or non-health professional from JAPAN on Sept 14, 2007. Male patient, 70 years of age, was diagnosed with cerebral infarction, pneumonia
and was treated with Argatroban. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, haematocrit decreased, haemorrhagic cerebral infarction, hepatic function abnormal. Argatroban dosage: 60 MG, QD, INTRAVENOUS; 20 MG, QD, INTRAVENOUS. During the same period patient was treated with FLUMARIN, ZANTAC, RADICURT, GRTPA, ASPIRIN, GAMOFA, WARFARIN. Patient recovered.Argatroban Side Effects Report #5522071-1
Argatroban side effect was reported by a Health Professional from JAPAN on Nov 01, 2007. Male patient, 70 years of age, was diagnosed with cerebral infarction, pneumonia
and was treated with Argatroban. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, haematocrit decreased, haemoglobin decreased, haemorrhagic cerebral infarction, hepatic function abnormal. Argatroban dosage: 60 MG, QD, INTRAVENOUS; 20 MG, QD, INTRAVENOUS. During the same period patient was treated with FLUMARIN, CLINDAMYCIN, ZANTAC, RADICUT, GRTPA, ASPIRIN, GAMOFA. Patient recovered.Argatroban Side Effects Report #4544432-X
Argatroban side effect was reported by a Health Professional from on Dec 21, 2004. Male patient was diagnosed with cerebral infarction and was treated with Argatroban. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, hepatic function abnormal. Argatroban dosage: 60 MG QD IV. During the same period patient was treated with GLYCEOL. Patient recovered.
Argatroban Side Effects Report #4562157-1
Argatroban side effect was reported by a Health Professional from on Jan 19, 2005. Male patient was diagnosed with cerebral infarction and was treated with Argatroban. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, cerebral infarction, hepatic function abnormal. Argatroban dosage: 60 MG QD IV. During the same period patient was treated with GLYCEOL. Patient recovered.